(Total Views: 535)
Posted On: 12/10/2020 9:14:30 PM
Post# of 154501
Re: Bored Lawyer #67627
No need for DSMC review if trial if fully enrolled and drug fully administered and 28 day primary endpoint data available.
Can unblind due to fast enrollment, 42 day interim not as necessary - just analyze that with the rest of the full study data
Can unblind due to fast enrollment, 42 day interim not as necessary - just analyze that with the rest of the full study data
(3)
(0)
